Follow

Submissions from 2026

PDF

Variation in Estimated Pharmacy Acquisition Costs Relative to NADAC: Evidence from a Multi-State Analysis, Bryan Amick

PDF

Opioid tapering and risk of cardiovascular diseases among older adults: A case-crossover study, Shadi Bazzazzadehgan, Yi Yang, Liang-Yuan Lin, John Bentley, Sujith Ramachandran, and Kaustuv Bhattacharya

PDF

Geographic Variation in Pharmacist Scope of Practice for PrEP Delivery Across the United States, Gabriel Ezenri and Bita Fayaz Farkhad

PDF

Motivational Interviewing Impact on Outcomes is Affected by Level of Interventionist Training: A Review of Systematic Reviews, Sneha Gaonkar, Jan Kavookjian, and Heqin Yang

PDF

Patients willingness to seek help from pharmacists in the management of rheumatoid arthritis: a qualitative study, Omkar Ghodke, Erin Holmes, Meagen Rosenthal, Yinan Huang, and Marie Barnard

PDF

Cost-Effectiveness of Donanemab and Lecanemab Over a Lifetime Horizon for Patients with Early Alzheimers Disease, Xiangxiang Jiang, Gang Lv, Amber Burroughs, Jun Wu, Jing Yuan, and Kevin Lu

PDF

Comparative Effectiveness of Augmentation, Switching, and Dose Escalation After Inadequate Antidepressant Response in Medicare Beneficiaries, Chih-Ting (Tim) Lai, Jingjing Qian, Cherry Jackson, Kimberly Garza, Jingyi Zheng, Richard Chapman, and Surachat Ngorsuraches

PDF

Incident Benzodiazepine Initiation Following Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Cohort Study, Parasto Mousavi, Lindsey Loera, Abolfazl Sadeghi, Smita Prasad, John Embers, Anton Avanceña, and Tyler Varisco

PDF

EVALUATING THE IMPACT OF OPIOID USE IN FUNCTIONAL LIMITATION AND HEALTHCARE UTILIZATION OF ARTHRITIC PATIENTS USING METHOTREXATE IN THE UNITED STATES, Oluwafeyisayo Obadimu

PDF

Reducing Opioid Exposure Through State Policy: Evidence from U.S. Prescribing Limits, Rasaq Oladapo, Olufunmilola Abraham, Patricia R. Freeman, Douglas Oyler, and Rachel Vickers-Smith

PDF

Comparing Sodium-Glucose cotransporter-2 Inhibitors (SGLT2i) versus Inhibitors of the renin-angiotensin system (RASi) In Heart Failure Patients with Alzheimers Disease and Related Dementia (ADRD), Junnan Qi and Kaustuv Bhattacharya